Company Profiles

driven by the PitchBook Platform

VentiRx Pharmaceuticals

2006 FOUNDED
M&A STATUS
11-20 EMPLOYEES
M&A LATEST DEAL TYPE
$35M LATEST DEAL AMOUNT
Description

Developer of small molecule product candidates designed to treat cancer. The company's small molecule product candidates target Toll-like receptor 8 (TLR8), enabling cancer patients to get improved treatment.

Website
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Acquirer
Primary Office
1191 Second Avenue
Suite 1105
Seattle, WA 98101
United States

+1 (206) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore VentiRx Pharmaceuticals’s full profile, request a free trial.

VentiRx Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 20-Jan-2017 $35M 00000 0000 Completed Generating Revenue
5. Later Stage VC (Series B) 30-Sep-2014 0000 00000 00000 Completed Generating Revenue
4. Corporate 03-Oct-2012 0000 000.00 Completed Generating Revenue
3. Early Stage VC (Series A) 12-Jan-2010 0000 000.00 0000 Completed Startup
2. Early Stage VC (Series A) 06-Mar-2007 $26.6M $28.9M 0000 Completed Startup
1. Seed Round 26-Jun-2006 $2.31M $2.31M 00.000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

VentiRx Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 0,000,000 00.000000 00.00 00 00 00 00 0.000
Series A 00,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series 1 2,312,500 $0.000100 $0.08 $1 $1 1x $1 4.79%
To view this company’s complete Cap Table, request access »

VentiRx Pharmaceuticals Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
ARCH Venture Partners Venture Capital Minority 000 0000 000000 0
Domain Associates Venture Capital Minority 000 0000 000000 0
Frazier Healthcare Partners Venture Capital Minority 000 0000 000000 0
MedImmune Ventures Corporate Venture Capital Minority 000 0000 000000 0

VentiRx Pharmaceuticals Executive Team (10)

Name Title Board
Seat
Contact
Info
Mona Newkirk Director, Clinical Operations
Timothy Fitzpatrick Head, Pharmaceutical Manufacturing
Kristi Manjarrez Vice President, Clinical Affairs
Tom Swallow Vice President, Finance and Administration
Tressa Randall Vice President, Regulatory Affairs

2 Former Executives

You’re viewing 5 of 10 executives. Get the full list »
Questions or concerns about this profile? Reach out to website-support@pitchbook.com